Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
Open Access
- 26 January 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 18 (1), 1-12
- https://doi.org/10.1186/s13058-015-0669-x
Abstract
Approximately 30 % of breast cancer patients receive chemotherapy, yet little is known about influences of current regimens on circulating lymphocyte levels and phenotypes. Similarly, clinico-pathological factors that modify these influences, and implications for future immune health remain mainly unexplored. We used flow-cytometry to assess circulating lymphocyte levels and phenotypes in 88 primary breast cancer patients before chemotherapy and at time-points from 2 weeks to 9 months after chemotherapy completion. We examined circulating titres of antibodies against pneumococcal and tetanus antigens using ELISAs. Levels of B, T and NK cells were significantly reduced 2 weeks after chemotherapy (p < 0.001). B cells demonstrated particularly dramatic depletion, falling to 5.4 % of pre-chemotherapy levels. Levels of all cells recovered to some extent, although B and CD4+ T cells remained significantly depleted even 9 months post-chemotherapy (p < 0.001). Phenotypes of repopulating B and CD4+ T cells were significantly different from, and showed no sign of returning to pre-chemotherapy profiles. Repopulating B cells were highly depleted in memory cells, with proportions of memory cells falling from 38 % to 10 % (p < 0.001). Conversely, repopulating CD4+ T cells were enriched in memory cells, which increased from 63 % to 75 % (p < 0.001). Differences in chemotherapy regimen and patient smoking were associated with significant differences in depletion extent or repopulation dynamics. Titres of anti-pneumococcal and anti-tetanus antibodies were both significantly reduced post-chemotherapy and did not recover during the study (p < 0.001). Breast cancer chemotherapy is associated with long-term changes in immune parameters that should be considered during clinical management.Keywords
This publication has 46 references indexed in Scilit:
- B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2Haematologica, 2012
- Long-Term Effects of Alemtuzumab on Regulatory and Memory T-Cell Subsets in Kidney TransplantationTransplantation, 2012
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- B‐cell diversity decreases in old age and is correlated with poor health statusAging Cell, 2009
- NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapyBritish Journal of Cancer, 2007
- Herpes Infections in Breast Cancer Patients Treated with Adjuvant ChemotherapyOncology, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation surveyBritish Journal of Haematology, 2002
- Docetaxel-induced lymphopenia in patients with solid tumorsCancer, 2000